Roswell Park is spearheading efforts to study innovative CAR T-cell therapies in addition to offering traditional treatment approaches.
Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center, offers guidance on what red flags may indicate a hematologic cancer in your patients to help you identify these complex and often difficult-to-treat ...
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.
Ryan Hare, PharmD, discusses the treatment of Myeloma Bone Disease. This lecture will review the myeloma bone microenvironment, discuss bone preservation benefits of treatments, describe aniti-myeloma properties, and highlight medication ...
Phillip McCarthy, MD, discusses autologous stem cell transplant/rescue following induction therapy, available therapies, and why a majority of patients will have progressive disease.
Hillary Jacobson, DPT, shares the importance of exercise in reducing fatigue in patients diagnosed with cancer.
A multidisciplinary research team led by Song Yao, PhD, Professor of Oncology in the Department of Cancer Prevention and Control at Roswell Park Comprehensive Cancer Center and Kara Kelly, MD, Chair of the Roswell Park Oishei Children’s ...
Patients who develop cytomegalovirus (CMV) infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, ...
Roswell Park researchers are working on strategies to modulate the immune response to cancer treatment and control by overcoming immunosuppression.
This site is intended for healthcare professionals